Sisaf

Shape Therapeutics

The company develops programmable RNA medicines and delivery systems for patients with genetic disorders and other hard-to-treat diseases.

Marina

This company develops nucleic acid therapeutics and delivery technologies for patients with rare diseases, arthritis, hypertension, and cancer.

Entos Pharmaceuticals Inc

This clinical-stage biotechnology company develops nucleic acid delivery platforms and genetic medicines for pharmaceutical partners and patients with rare diseases and metabolic conditions.

Argonaute RNA

This biotechnology firm develops bispecific siRNA therapeutics for cardiometabolic diseases, serving pharmaceutical partners and research institutions engaged in advanced therapeutic research.

Airna

This company develops RNA editing therapeutics to treat patients with rare genetic and common cardiometabolic diseases.

Skyhawk Therapeutics

This company develops small molecules that modulate RNA for patients with rare neurological, oncological, and autoimmune diseases.

Entos Pharmaceuticals Inc

This company develops nucleic acid delivery technology and genetic medicines for patients with rare diseases and unmet clinical needs.

Spot Biosystems

This company develops non-viral gene therapy delivery platforms using extracellular vesicles to treat genetic diseases for pharmaceutical partners and healthcare providers.